Predicting ILD from Hypersensitivity Pneumonitis Request More Information Trial Objective Researchers believe they will be able to predict which patients with chronic Hypersensitivity Pneumonitis (HP) will develop interstitial lung disease (ILD) by looking at their genes and biomarkers in their blood. For this observational study, researchers will collect samples and data from participants with rapidly progressing HP and slowly progressing HP to look for patterns that can help predict the development of ILD and form specialized treatment plans. Enrollment Active Clinical Trials Currently Recruiting Who Can Participate Adults who have been diagnosed with Hypersensitivity Pneumonitis (HP). Age: 18-90 Gender: Any Gender Estimated Time Commitment Clinic visits every 6 months over approximately 2 years (4 visits total) × Payments are intended to compensate the participant for their time and effort during the study. Payments are typically given to the participant at the end of each completed study visit. Reimbursements are intended to compensate the participant for travel-related expenses. They must be approved by the study staff and require you to turn in receipts. Travel reimbursement will vary from study to study. Payment & Reimbursement Payment: Not Provided Travel Reimbursement: Not Available Trial Contact For more information, contact: Elizabeth Del Real 303.398.1172 Request More Information Trial Location National Jewish Main Campus, Denver, CO Trial Sponsors Investigator Initiated with funding from Boehringer Ingelheim Principal Investigators Evans Fernández, MD, MS + × Evans Fernández, MD, MS Associate Professor Division of Pulmonary, Critical Care & Sleep Medicine Department of Medicine View Full Profile Patient Rating 4.9 out of 5 stars Make an Appoinment Co-Investigators Joshua Solomon, MD + × Joshua Solomon, MD Director, Interstitial Lung Disease Program Associate Professor Department of Medicine Division of Pulmonary, Critical Care & Sleep Medicine Section of Critical Care Medicine View Full Profile Patient Rating 4.8 out of 5 stars Make an Appoinment Lisa Maier, MD, MSPH, FCCP + × Lisa Maier, MD, MSPH, FCCP Professor Director, Division of Env & Occ Health Science Core Clinical Lab Chief, Division of Environmental & Occupational Health Sciences Department of Medicine View Full Profile Patient Rating 4.9 out of 5 stars Make an Appoinment Michael Mohning, MD + × Michael Mohning, MD Assistant Professor Department of Medicine Division of Pulmonary, Critical Care & Sleep Medicine Interstitial Lung Disease Program View Full Profile Patient Rating 4.9 out of 5 stars Make an Appoinment Rebecca Keith, MD + × Rebecca Keith, MD Associate Professor Department of Medicine Division of Pulmonary, Critical Care & Sleep Medicine Interstitial Lung Disease Program Autoimmune Lung Center View Full Profile Patient Rating 4.5 out of 5 stars Make an Appoinment Tristan Huie, MD + × Tristan Huie, MD Associate Professor Division of Pulmonary, Critical Care & Sleep Medicine Department of Medicine View Full Profile Patient Rating 4.7 out of 5 stars Make an Appoinment Zulma Yunt, MD + × Zulma Yunt, MD Assistant Professor of Medicine Department of Medicine Division of Pulmonary, Critical Care & Sleep Medicine View Full Profile Patient Rating 4.7 out of 5 stars Make an Appoinment Request More Information By completing this form, you agree to learn more about this study and see if you qualify. First Name:* Last Name:* Email Address:* Phone:* I would also like to receive periodic emails with health information, news and clinical research updates from National Jewish Health: YesNo
Trial Objective Researchers believe they will be able to predict which patients with chronic Hypersensitivity Pneumonitis (HP) will develop interstitial lung disease (ILD) by looking at their genes and biomarkers in their blood. For this observational study, researchers will collect samples and data from participants with rapidly progressing HP and slowly progressing HP to look for patterns that can help predict the development of ILD and form specialized treatment plans.